Verici Dx plc
Verici Dx plc, together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States. The company develops Tutivia, a post-transplant diagnostic test focused on acute cellular rejection, including sub-clinical rejection; and Protega, a liquid biopsy to predict the risk of fibrosis and long-term graft failur… Read more
Market Cap & Net Worth: Verici Dx plc (VRCDF)
Verici Dx plc (PINK:VRCDF) has a market capitalization of $45.40 Million ($45.40 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #31632 globally and #10408 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Verici Dx plc's stock price $0.03 by its total outstanding shares 1513394127 (1.51 Billion).
Verici Dx plc Market Cap History: 2022 to 2025
Verici Dx plc's market capitalization history from 2022 to 2025. Data shows change from $211.88 Million to $45.40 Million (-53.03% CAGR).
Verici Dx plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Verici Dx plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
13.60x
Verici Dx plc's market cap is 13.60 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $166.47 Million | $1.01 Million | -$8.73 Million | 164.34x | N/A |
| 2024 | $45.40 Million | $3.34 Million | -$5.87 Million | 13.60x | N/A |
Competitor Companies of VRCDF by Market Capitalization
Companies near Verici Dx plc in the global market cap rankings as of March 18, 2026.
Key companies related to Verici Dx plc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Verici Dx plc Historical Marketcap From 2022 to 2025
Between 2022 and today, Verici Dx plc's market cap moved from $211.88 Million to $ 45.40 Million, with a yearly change of -53.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $45.40 Million | 0.00% |
| 2024 | $45.40 Million | -72.73% |
| 2023 | $166.47 Million | -21.43% |
| 2022 | $211.88 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Verici Dx plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $45.40 Million USD |
| MoneyControl | $45.40 Million USD |
| MarketWatch | $45.40 Million USD |
| marketcap.company | $45.40 Million USD |
| Reuters | $45.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.